Trexima Approvable Letter Another Headache For Pozen
This article was originally published in The Pink Sheet Daily
Executive Summary
Pozen and GlaxoSmithKline had been seeking a third quarter launch.
You may also be interested in...
GSK/Pozen Win Long-awaited Approval For Combo Migraine Drug
Treximet will hit the U.S. market in mid-May, GSK says.
GSK/Pozen Win Long-awaited Approval For Combo Migraine Drug
Treximet will hit the U.S. market in mid-May, GSK says.
Imitrex "Authorized" Generic Launch Planned In Q4 2008
GlaxoSmithKline and Dr. Reddy's reach settlement agreement on the migraine tablets allowing a generic launch several months prior to patent expiration.